Sharma, Surendra K <br/><br/>
Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Oct 2002 
 - 916-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1073-449X 
<br/><br/><label>Standard No.: </label>10.1164/rccm.2108091  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alleles<br/>Antitubercular Agents--adverse effects<br/>Chemical and Drug Induced Liver Injury--epidemiology<br/>Female<br/>Follow-Up Studies<br/>Genetic Predisposition to Disease<br/>HLA-DQ Antigens--genetics<br/>HLA-DR Antigens--genetics<br/>Haplotypes<br/>Humans<br/>Immunogenetics<br/>India--epidemiology<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Risk Factors<br/>Serum Albumin--metabolism<br/>Tuberculosis, Pulmonary--complications